These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 17003814

  • 1. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P, Persson PB, Hansell P, Lagerqvist B.
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [Abstract] [Full Text] [Related]

  • 2. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD.
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [Abstract] [Full Text] [Related]

  • 3. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 4. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G, Baber U, Mastoris I, Vlachojannis GJ, Yu J, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Nikolsky E, Wong SC, Theodoropoulos KN, Dangas GD, Mehran R.
    Catheter Cardiovasc Interv; 2016 Mar 05; 87(4):703-9. PubMed ID: 26481591
    [Abstract] [Full Text] [Related]

  • 5. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282
    [Abstract] [Full Text] [Related]

  • 6. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C, Batisse A, Collet JP, Batisse JP, Choussat R, Beygui F, Helft G, Montalescot G, Metzger JP.
    Catheter Cardiovasc Interv; 2006 Jun 01; 67(6):852-8. PubMed ID: 16649230
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
    Song T, Song M, Ge Z, Li Y, Shi P, Sun M.
    J Interv Cardiol; 2017 Jun 01; 30(3):281-285. PubMed ID: 28421628
    [Abstract] [Full Text] [Related]

  • 8. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS.
    JACC Cardiovasc Interv; 2009 Jul 01; 2(7):645-54. PubMed ID: 19628188
    [Abstract] [Full Text] [Related]

  • 9. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
    Bellemain-Appaix A, Beygui F, Lesty C, Gupta S, Silvain J, Le Feuvre C, Cayla G, Allali Y, Montalescot G, Collet JP.
    Catheter Cardiovasc Interv; 2012 Apr 01; 79(5):823-33. PubMed ID: 21618678
    [Abstract] [Full Text] [Related]

  • 10. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC, Wu Q, Wang C, Li DY, Wang ZR.
    J Cardiol; 2014 Apr 01; 63(4):260-8. PubMed ID: 24397991
    [Abstract] [Full Text] [Related]

  • 11. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.
    Am J Cardiol; 2011 Jul 15; 108(2):189-94. PubMed ID: 21545991
    [Abstract] [Full Text] [Related]

  • 12. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM, Malik JA, Manske CL, Kasiske BL, Dickinson SE, Herzog CA, Wilson RF, Das G, Panetta CJ.
    J Invasive Cardiol; 2005 Apr 15; 17(4):211-5. PubMed ID: 15831975
    [Abstract] [Full Text] [Related]

  • 13. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME, Esplugas E, Piessens J, Rasch W.
    Circulation; 2000 Jan 18; 101(2):131-6. PubMed ID: 10637198
    [Abstract] [Full Text] [Related]

  • 14. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940
    [Abstract] [Full Text] [Related]

  • 15. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS.
    Circ Cardiovasc Interv; 2010 Aug 01; 3(4):351-8. PubMed ID: 20647563
    [Abstract] [Full Text] [Related]

  • 16. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators.
    N Engl J Med; 2003 Feb 06; 348(6):491-9. PubMed ID: 12571256
    [Abstract] [Full Text] [Related]

  • 17. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y, Hu S, Liu Y, Zhao R, Wang L, Fu G, He Q, Su X, Zheng Y, Qi X, Liu H, Wang J, Gao W, Wang M, Liu S, Zheng X, He B, Yang P, Zhou S, Gao C, Qiu C.
    EuroIntervention; 2012 Nov 22; 8(7):830-8. PubMed ID: 23045301
    [Abstract] [Full Text] [Related]

  • 18. Renal effects of cardiac angiography with different low-osmolar contrast media.
    Donadio C, Lucchesi A, Ardini M, Tramonti G, Chella P, Magagnini E, Bianchi C.
    Ren Fail; 2001 Nov 22; 23(3-4):385-96. PubMed ID: 11499554
    [Abstract] [Full Text] [Related]

  • 19. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC, Lyon SG, Berry CC.
    Radiology; 1997 Jun 22; 203(3):605-10. PubMed ID: 9169676
    [Abstract] [Full Text] [Related]

  • 20. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    J Cardiovasc Med (Hagerstown); 2010 Mar 22; 11(3):199-206. PubMed ID: 19829124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.